Literature DB >> 19436309

The rewards and challenges of array-based karyotyping for clinical oncology applications.

J M Hagenkord, C C Chang.   

Abstract

Mesh：

Year:  2009        PMID： 19436309     DOI： 10.1038/leu.2009.24

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

1.  The vanguard has arrived in the clinical laboratory: array-based karyotyping for prognostic markers in chronic lymphocytic leukemia.

Authors:  Shelly R Gunn
Journal:  J Mol Diagn       Date:  2010-01-14       Impact factor: 5.568

2.  Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays.

Authors:  Jill M Hagenkord; Federico A Monzon; Shera F Kash; Stan Lilleberg; Qingmei Xie; Jeffrey A Kant
Journal:  J Mol Diagn       Date:  2010-01-14       Impact factor: 5.568

3.  Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity.

Authors:  Shelly Gunn; I-Tien Yeh; Irina Lytvak; Budi Tirtorahardjo; Natasha Dzidic; Soheila Zadeh; Jaeweon Kim; Chris McCaskill; Lony Lim; Mercedes Gorre; Mansoor Mohammed
Journal:  BMC Cancer       Date:  2010-07-28       Impact factor: 4.430

Review 4.  Not All Next Generation Sequencing Diagnostics are Created Equal: Understanding the Nuances of Solid Tumor Assay Design for Somatic Mutation Detection.

Authors:  Phillip N Gray; Charles L M Dunlop; Aaron M Elliott
Journal:  Cancers (Basel)       Date:  2015-07-17       Impact factor: 6.639

5.  Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?

Authors:  Jess F Peterson; Nidhi Aggarwal; Clayton A Smith; Susanne M Gollin; Urvashi Surti; Aleksandar Rajkovic; Steven H Swerdlow; Svetlana A Yatsenko
Journal:  Oncotarget       Date:  2015-08-07

6.  TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.

Authors:  Phillip N Gray; Huy Vuong; Pei Tsai; Hsaio-Mei Lu; Wenbo Mu; Vickie Hsuan; Jayne Hoo; Swati Shah; Lisa Uyeda; Susanne Fox; Harshil Patel; Mike Janicek; Sandra Brown; Lavinia Dobrea; Lawrence Wagman; Elizabeth Plimack; Ranee Mehra; Erica A Golemis; Marijo Bilusic; Matthew Zibelman; Aaron Elliott
Journal:  Oncotarget       Date:  2016-10-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.